January - March 2023, Volume 19, Issue 1

Lefter R, Balmus IM, Ciobica A, I Antioch, DC Ababei, Bild W, Hritcu LD, Musteata M, Timofte D , Hogas S

Central and Peripheral Effect of MPTP Via Dose-Dependent Magnesium Modulation

Acta Endo (Buc) 2023, 19 (1): 36-48
doi: 10.4183/aeb.2023.36

Background. Recent studies suggested that MPTP could cause gastrointestinal motility deficits additionally to its nonconclusive and controverted effects on the CNS (behavior and brain oxidative stress) in rats. A possible interaction between MPTP typical impairments and magnesium modulatory potential was previously suggested, as magnesium role was described in neuroprotection, gastrointestinal function, and oxidative stress. Aim. To investigate the possible modulatory effect of several magnesium intake formulations (via drinking water) in MPTP neurotoxicity and functional gastrointestinal impairment induction. Materials and Methods. Adult male Wistar rats were subjected to 3-week magnesium intake-controlled diets (magnesium depleted food and magnesium enriched drinking water) previously to acute subcutaneous MPTP treatment (30 mg/ kg body weight). Gastrointestinal motility (one hour stool collection test), and behavioral patterns (Y maze task, elevated plus maze test, open field test, forced swim test) were evaluated. Followingly, brain and bowel samples were collected, and oxidative stress was evaluated (glutathione peroxidase activity, malondial-dehyde concentrations). Results. MPTP could lead to magnesium intakedependent constipation-like gastrointestinal motility impairments, anxiety- and depressive-like affective behavior changes, and mild pain tolerance defects. Also, we found similar brain and intestinal patterns in magnesium-dependent oxidative stress. Conclusion. While the MPTP effects in normal magnesium intake could be regarded as not fully relevant in rat models and limited to the current experimental conditions, the abnormalities observed in the affective behavior, gastrointestinal status, pain tolerance, peripheric and central oxidative status could be indicative of the extent of the systemic effects of MPTP that are not restricted to the CNS level, but also to gastro-intestinal system.

Keywords: Parkinson’s disease, animal model, MPTP, locomotor impairment, anxious behavior, depressivelike behavior, gastrointestinal.

Correspondence: Luminita Diana Hritcu MD, “Ion Ionescu de la Brad” University of Agricultural Science and Veterinary Medicine, Internal Medicine Clinic, Faculty of Veterinary Medicine, 6 Sadoveanu Alley, Iasi, 700490, Romania, E-mail: lumidih@yahoo.com